Search results
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
CNBC· 27 minutes agoA patient injects herself with an insulin pen. The rivalry between Eli Lilly and Novo Nordisk...
Russian Propagandist Sounds Alarm Over Mossad Agent ‘Eli Copter’
The Daily Beast via Yahoo News· 13 minutes agoIn an episode of his show on Rossiya 1 late Monday, Solovyov raged against those who celebrated the...
IBD Stock Of The Day Eli Lilly Breaks Out On Its Way To A Record High
Investor's Business Daily· 3 hours agoEli Lilly is Tuesday's IBD Stock Of The Day after shares surged into a buy zone, again, on promising...
Eli Lilly’s stock on pace for record close as Crohn’s disease trial hits the mark
Market Watch· 2 hours agoEli Lilly & Co. LLY shares were on pace for a record closing high Tuesday after the drugmaker...
If You'd Invested $10,000 in Eli Lilly Stock 5 Years Ago, Here's How Much You'd Have Today
The Motley Fool via AOL· 4 hours agoEli Lilly's (NYSE: LLY) broad portfolio of drugs has helped the company's earnings climb over the...
Ask Eli: Navigating mortgage challenges during a divorce | ARLnow.com
ARLnow.com· 2 hours agoThis regularly scheduled sponsored Q&A column is written by Eli Tucker, Arlington-based Realtor and...
Eli Manning Wants His Own Team as Private Equity Targets the NFL
Bloomberg· 1 day agoEli Manning, the retired quarterback who led the underdog New York Giants to two Super Bowl...
Eli Lilly stock hits new highs after a regulatory win in China. This is a big deal
CNBC· 3 hours agoEvery weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20...
Eli Lilly's diabetes drug tirzepatide gets approval in China
Reuters via Yahoo Finance· 10 hours agoSHANGHAI (Reuters) -Eli Lilly said on Tuesday its diabetes drug tirzepatide has received approval...
Keysight Technologies, Nordson fall; Eli Lilly, Lam Research rise, Tuesday, 5/21/2024
Associated Press· 1 hour agoStocks that are trading heavily or have substantial price changes on Tuesday: Keysight Technologies, Nordson fall; Eli Lilly, Lam Research rise.